Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Thoracic 4

Conditions

Vomiting 39Nausea 31Neoplasms 10Breast Neoplasms 10Lymphoma 9Multiple Myeloma 7Ovarian Neoplasms 6Lymphoma, Non-Hodgkin 6Leukemia, Myeloid, Acute 6Sezary Syndrome 4Myeloproliferative Disorders 4Leukemia 4Carcinoma, Non-Small-Cell Lung 4Pruritus 3Primary Myelofibrosis 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pdgfra-Associated Chronic Eosinophilic Leukemia 3Neoplasms, Plasma Cell 3Myelodysplastic Syndromes 3Mycosis Fungoides 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Neutrophilic, Chronic 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3

Interventions

Carboplatin 784Pemetrexed 607Cisplatin 545Paclitaxel 491pembrolizumab 464Docetaxel 440Gemcitabine 328Erlotinib Hydrochloride 307Radiotherapy 258Nivolumab 244Bevacizumab 233osimertinib 178Drug Therapy 164durvalumab 157atezolizumab 135Gefitinib 134Radiosurgery 133Vinorelbine 111Cetuximab 97130-nm albumin-bound paclitaxel 94Ipilimumab 86Magnetic Resonance Spectroscopy 84Taxes 79Surgical Procedures, Operative 74Afatinib 68Albumin-Bound Paclitaxel 66Specimen Handling 61Etoposide 61Cyclophosphamide 60tislelizumab 59

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Carcinoma, Non-Small-Cell Lung × Aprepitant × Clear all
NCT02646020 2021-05-18

EGFR-TKIs

Sun Yat-sen University

Phase 2 Completed
138 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Pruritus

NCT02364804 2020-09-01

A Study to Evaluate the Efficacy of Anti-emetic Drug Upon the Combination Chemotherapy for Non-small Cell Lung Cancer

Shiga University

Completed
10 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02161991 2020-03-26

Aprepitant for Chemotherapy Induced Nausea and Vomiting in Chinese Advanced Non-small Cell Lung Cancers

Hunan Province Tumor Hospital

Phase 3 Completed
244 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02407600 2015-04-03

Study Assessing Fosaprepitant in Advanced NSCLC Patients Treated With Carboplatin Based Chemotherapy

State University of New York - Upstate Medical University

Phase 2 Unknown
150 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡